CN104662002A - 取代脲类化合物的合成方法 - Google Patents

取代脲类化合物的合成方法 Download PDF

Info

Publication number
CN104662002A
CN104662002A CN201380050477.4A CN201380050477A CN104662002A CN 104662002 A CN104662002 A CN 104662002A CN 201380050477 A CN201380050477 A CN 201380050477A CN 104662002 A CN104662002 A CN 104662002A
Authority
CN
China
Prior art keywords
alkyl
substituted
heterocyclyl
aryl
heteroaryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201380050477.4A
Other languages
English (en)
Chinese (zh)
Inventor
多梅尼克·鲁索
若热·布鲁诺·赖斯·瓦农
威廉·马东
蒂博尔·埃塞尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bial Portela and Cia SA
Original Assignee
Bial Portela and Cia SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bial Portela and Cia SA filed Critical Bial Portela and Cia SA
Publication of CN104662002A publication Critical patent/CN104662002A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
CN201380050477.4A 2012-07-27 2013-07-26 取代脲类化合物的合成方法 Pending CN104662002A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261676554P 2012-07-27 2012-07-27
US61/676,554 2012-07-27
PCT/PT2013/000050 WO2014017938A2 (en) 2012-07-27 2013-07-26 Process for the synthesis of substituted urea compounds

Publications (1)

Publication Number Publication Date
CN104662002A true CN104662002A (zh) 2015-05-27

Family

ID=49003969

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201380050477.4A Pending CN104662002A (zh) 2012-07-27 2013-07-26 取代脲类化合物的合成方法

Country Status (8)

Country Link
US (1) US20150197503A1 (cg-RX-API-DMAC7.html)
EP (1) EP2882712A2 (cg-RX-API-DMAC7.html)
JP (1) JP2015528013A (cg-RX-API-DMAC7.html)
CN (1) CN104662002A (cg-RX-API-DMAC7.html)
BR (1) BR112015001769A2 (cg-RX-API-DMAC7.html)
CA (1) CA2880299A1 (cg-RX-API-DMAC7.html)
RU (1) RU2015104103A (cg-RX-API-DMAC7.html)
WO (1) WO2014017938A2 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201401198D0 (en) 2014-01-24 2014-03-12 Bial Portela & Ca Sa Process for the syntheis of substituted urea compounds
WO2017210545A1 (en) 2016-06-02 2017-12-07 Cadent Therapeutics, Inc. Potassium channel modulators
PL3571193T3 (pl) 2017-01-23 2022-04-25 Cadent Therapeutics, Inc. Modulatory kanału potasowego
CR20230030A (es) 2018-02-27 2023-03-10 Incyte Corp Imidazopirimidinas y triazolopirimidinas como inhibidores de a2a / a2b (divisional 2020-0441)
MA52940A (fr) 2018-05-18 2021-04-28 Incyte Corp Dérivés de pyrimidine fusionnés utilisés en tant qu'inhibiteurs de a2a/a2b
CN117304191A (zh) 2018-07-05 2023-12-29 因赛特公司 作为a2a/a2b抑制剂的稠合吡嗪衍生物
BR112021007552A2 (pt) 2018-10-22 2021-07-27 Cadent Therapeutics, Inc. formas cristalinas de moduladores de canal de potássio
TWI829857B (zh) 2019-01-29 2024-01-21 美商英塞特公司 作為a2a / a2b抑制劑之吡唑并吡啶及三唑并吡啶

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN86104173A (zh) * 1985-07-01 1987-01-28 詹森药业有限公司 新型5-咪唑羧酸衍生物的制备方法和它们的使用
US4973588A (en) * 1988-02-10 1990-11-27 Mitsui Petrochemical Industries, Ltd. Imidazole derivatives having anti-hypoxia properties
CN1800198A (zh) * 2006-01-18 2006-07-12 中国药科大学 一种制备大环内酯类半合成抗生素泰利霉素的方法
CN1914180A (zh) * 2004-02-02 2007-02-14 塞诺菲-安万特德国有限公司 作为激素敏感性脂肪酶抑制剂的吲唑衍生物
CN102333568A (zh) * 2008-12-24 2012-01-25 比亚尔-珀特拉和Ca股份公司 药物化合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1238971A (cg-RX-API-DMAC7.html) * 1968-03-02 1971-07-14
DE2458965C3 (de) * 1974-12-13 1979-10-11 Bayer Ag, 5090 Leverkusen 3-Amino-indazol-N-carbonsäure-Derivate, Verfahren zu ihrer Herstellung sowie sie enthaltende Arzneimittel
EP0014810A3 (en) * 1979-01-18 1980-11-26 Fbc Limited Pesticidal pyrazoles, their production, compositions and uses, as well as intermediates and their preparation
JPH01203368A (ja) * 1988-02-10 1989-08-16 Mitsui Petrochem Ind Ltd チオイミダゾール誘導体
FR2674855B1 (fr) * 1991-04-03 1994-01-14 Synthelabo Derives de piperidine, leur preparation et leur application en therapeutique.
JP3457669B2 (ja) * 1992-10-28 2003-10-20 富山化学工業株式会社 新規な１，２−ベンゾイソオキサゾール誘導体またはその塩，それらからなる脳保護剤
US20030203862A1 (en) * 1998-03-26 2003-10-30 Miraglia Loren J. Antisense modulation of MDM2 expression
WO2001016312A2 (en) * 1999-08-31 2001-03-08 Ribozyme Pharmaceuticals, Inc. Nucleic acid based modulators of gene expression
WO2002083111A2 (en) * 2001-04-16 2002-10-24 Tanabe Seiyaku Co., Ltd. Imidazole, thiazole and oxazole derivatives and their use for the manufacture of a medicament for the treatment and/or prevention of pollakiuria or urinary incontinence
US7329662B2 (en) * 2003-10-03 2008-02-12 Hoffmann-La Roche Inc. Pyrazolo-pyridine
CA2806701A1 (en) 2010-07-29 2012-02-02 Bial - Portela & Ca, S.A. Process for the synthesis of substituted urea compounds

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN86104173A (zh) * 1985-07-01 1987-01-28 詹森药业有限公司 新型5-咪唑羧酸衍生物的制备方法和它们的使用
US4973588A (en) * 1988-02-10 1990-11-27 Mitsui Petrochemical Industries, Ltd. Imidazole derivatives having anti-hypoxia properties
CN1914180A (zh) * 2004-02-02 2007-02-14 塞诺菲-安万特德国有限公司 作为激素敏感性脂肪酶抑制剂的吲唑衍生物
CN1800198A (zh) * 2006-01-18 2006-07-12 中国药科大学 一种制备大环内酯类半合成抗生素泰利霉素的方法
CN102333568A (zh) * 2008-12-24 2012-01-25 比亚尔-珀特拉和Ca股份公司 药物化合物

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
C. ROBIN GANELLIN, ET AL.: "Design of Potent Non-Thiourea H3-Receptor Histamine Antagonists", 《JOURNAL OF MEDICINAL CHEMISTRY》 *
CONOR O"BRIEN: "THE REARRAYGEMEKT OF KETOXIME O-SULFONATES TO AMINO KETONES", 《CHEMICAL REVIEWS》 *
RAINER M. LUOND，ET AL.: "Assessment of the Active-Site Requirements of 5-Aminolaevulinic Acid Dehydratase: Evaluation of Substrate and Product Analogues as Competitive Inhibitors", 《J. ORG. CHEM.》 *
REGISTRY: "RN 1233855-18-9", 《STN COLUMBUS》 *

Also Published As

Publication number Publication date
US20150197503A1 (en) 2015-07-16
RU2015104103A (ru) 2016-09-20
WO2014017938A2 (en) 2014-01-30
BR112015001769A2 (pt) 2017-08-22
JP2015528013A (ja) 2015-09-24
WO2014017938A3 (en) 2014-03-20
CA2880299A1 (en) 2014-01-30
EP2882712A2 (en) 2015-06-17

Similar Documents

Publication Publication Date Title
CN104662002A (zh) 取代脲类化合物的合成方法
AU2010244684B2 (en) Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
JP7168773B2 (ja) イソインドリン化合物、その調製方法、医薬組成物および使用
AU2016231289B2 (en) Benzazepine dicarboxamide compounds
JP5487214B2 (ja) キナーゼ阻害剤として有用なカルバゾールカルボキシアミド化合物
CN114174281B (zh) 细胞周期蛋白依赖性激酶7(cdk7)的降解剂及其用途
CA3008653A1 (en) Bruton's tyrosine kinase inhibitors
TW201018684A (en) New compounds
CA2608378A1 (fr) Nouveaux derives du fluorene, compositions les contenant et utilisation
TW200815414A (en) Inhibitors of C-FMS kinase
CA2513631A1 (fr) Derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
CA2718528A1 (en) Substituted 4-hydroxypyrimidine-5-carboxamides
EP2235003A1 (fr) Derives d'indole 2-carboxamides et d'azaindole 2-carboxamides substitues par un groupe silanyle, leur preparation et leur application en therapeutique
FR2928645A1 (fr) Nouveaux derives de carbazole inhibiteurs d'hsp90, compositions les contenant et utilisation
WO2006028226A1 (ja) 新規イミダゾリジン誘導体およびその用途
CN1681507A (zh) 新的螺稠合喹唑酮和它们作为磷酸二酯酶抑制剂的用途
TW201609696A (zh) 用於製備３－（３－氯－１ｈ－吡唑－１－基）吡啶的方法（三）
CN103140478A (zh) 取代的脲化合物的合成方法
HK1203943A1 (en) Quinazolinedione derivative
WO2011140164A1 (en) Aza-indole derivatives useful as modulators of faah
JPWO2011065420A1 (ja) ６−置換−１−メチル−１ｈ−ベンズイミダゾール誘導体の製造法及びその製造中間体
EP2185558B1 (fr) Dérivés de n-hétéroaryl-carboxamides tricycliques, leur préparation et leur application en thérapeutique
CN105934431B (zh) 取代脲类化合物的制备方法
JP2004115450A (ja) 医薬組成物
TW202506110A (zh) 作為ｕｓｐ１抑制劑之稠合吡唑衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
AD01 Patent right deemed abandoned

Effective date of abandoning: 20190531

AD01 Patent right deemed abandoned